CVS Health Corp vs Vanguard Information Technology Index Fund ETF — how do they compare? CVS Health Corp trades at $85.77 (market cap $112.29B), while Vanguard Information Technology Index Fund ETF trades at $128.27 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is the larger of the two by market cap, and CVS Health Corp pays a 3.03% dividend while Vanguard Information Technology Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Vanguard Information Technology Index Fund ETF for 129 Days on average.
| CVS | VGT | |
|---|---|---|
Market Cap | $112.29B | $170.20B |
Volume | 7,763,676 | 5,132,883 |
Sector | Health | — |
52-Week High | $110.60 | $129.79 |
52-Week Low | $70.08 | $83.59 |
Typical Hold Time | 83 Days | 129 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
VGT trades at $129.37, down 0.32% on the day, with a bullish technical signal driven by moving averages. The ETF recently reached a new 52-week high, reflecting strong momentum in the technology sector. Recent news highlights its historical performance and low expense ratio compared to peers, though RSI levels suggest potential overbought conditions.
The outlook remains positive given the tech sector's growth trajectory and institutional inflows, but risks include concentration in top holdings and sensitivity to AI sector volatility. Long-term investors may benefit from sector exposure, though near-term pullbacks are possible.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →